Omnicell, Inc.OMCLNASDAQ
Loading
Year-over-year research & development expense growth
Percentile
P13
Within normal range
vs 5Y Ago
-3.3x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -6.12% |
| Q3 2025 | 11.35% |
| Q2 2025 | 5.10% |
| Q1 2025 | -20.80% |
| Q4 2024 | 22.08% |
| Q3 2024 | 0.60% |
| Q2 2024 | -2.96% |
| Q1 2024 | -18.92% |
| Q4 2023 | 10.45% |
| Q3 2023 | 4.94% |
| Q2 2023 | 1.13% |
| Q1 2023 | -19.48% |
| Q4 2022 | 12.88% |
| Q3 2022 | -4.49% |
| Q2 2022 | 5.29% |
| Q1 2022 | 14.05% |
| Q4 2021 | 12.68% |
| Q3 2021 | 6.94% |
| Q2 2021 | 13.26% |
| Q1 2021 | 3.86% |
| Q4 2020 | 1.88% |
| Q3 2020 | -27.04% |
| Q2 2020 | 11.68% |
| Q1 2020 | -2.31% |
| Q4 2019 | 14.85% |
| Q3 2019 | -1.32% |
| Q2 2019 | 4.79% |
| Q1 2019 | -5.36% |
| Q4 2018 | 7.49% |
| Q3 2018 | 1.89% |
| Q2 2018 | -6.20% |
| Q1 2018 | 4.05% |
| Q4 2017 | -3.17% |
| Q3 2017 | -2.94% |
| Q2 2017 | 0.64% |
| Q1 2017 | 12.76% |
| Q4 2016 | -2.37% |
| Q3 2016 | 10.66% |
| Q2 2016 | -0.32% |
| Q1 2016 | 50.10% |